Your browser doesn't support javascript.
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.
Ruscitti, Piero; Bruno, Federico; Berardicurti, Onorina; Acanfora, Chiara; Pavlych, Viktoriya; Palumbo, Pierpaolo; Conforti, Alessandro; Carubbi, Francesco; Di Cola, Ilenia; Di Benedetto, Paola; Cipriani, Paola; Grassi, Davide; Masciocchi, Carlo; Iagnocco, Annamaria; Barile, Antonio; Giacomelli, Roberto.
  • Ruscitti P; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Bruno F; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Berardicurti O; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Acanfora C; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Pavlych V; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Palumbo P; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Conforti A; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Carubbi F; Department of Medicine, ASL 1 Avezzano Sulmona L'Aquila, L'Aquila, Abruzzo, Italy.
  • Di Cola I; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Di Benedetto P; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Cipriani P; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Grassi D; Department of Clinical Medicine Life Health and Environmental Sciences, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Masciocchi C; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Iagnocco A; Dipartimento Scienze Cliniche e Biologiche, Università degli Studi di Torino, Torino, Italy.
  • Barile A; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
  • Giacomelli R; Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy roberto.giacomelli@cc.univaq.it.
Ann Rheum Dis ; 81(11): e221, 2022 11.
Article in English | MEDLINE | ID: covidwho-751547
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Still's Disease, Adult-Onset / Macrophage Activation Syndrome / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2020-218909

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Still's Disease, Adult-Onset / Macrophage Activation Syndrome / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2020-218909